Clinical course of asymptomatic duodenal subepithelial lesions
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: There is limited knowledge regarding the management of duodenal subepithelial lesions (SELs) owing to a lack of understanding of their natural course. This study aimed to assess the natural course of asymptomatic duodenal SELs and provide management recommendations. Methods: Patients diagnosed with duodenal SELs and followed up for a minimum of 6 months were retrospectively investigated. Results: Among the 443,533 patients who underwent esophagogastroduodenoscopy between 2008 and 2020, duodenal SELs were identified in 0.39% (1,713 patients). Among them, 396 duodenal SELs were monitored for a median period of 72.5 months (interquartile range, 37.7–111.3 mo). Of them, 16 SELs (4.0%) showed substantial changes in size or morphology at a median follow-up of 35.1 months (interquartile range, 21.7–51.4 mo). Of these SELs with substantial changes, tissues of two SELs were acquired using endoscopic ultrasound-guided fine needle aspiration biopsy: one was a lipoma and the other was non-diagnostic. Three SELs were surgically or endoscopically removed; two were diagnosed as gastrointestinal stromal tumors, and one was a lipoma. An initial size of 20 mm or larger was associated with substantial changes during follow-up (p = 0.016). Conclusions: While the majority of duodenal SELs may not exhibit substantial interval changes, regular follow-up with endoscopy may be necessary for cases with an initial size of 20 mm or larger, considering a possibility of malignancy.
Abstract
Background/Aims: There is limited knowledge regarding the management of duodenal subepithelial lesions (SELs) owing to a lack of understanding of their natural course. This study aimed to assess the natural course of asymptomatic duodenal SELs and provide management recommendations. Methods: Patients diagnosed with duodenal SELs and followed up for a minimum of 6 months were retrospectively investigated. Results: Among the 443,533 patients who underwent esophagogastroduodenoscopy between 2008 and 2020, duodenal SELs were identified in 0.39% (1,713 patients). Among them, 396 duodenal SELs were monitored for a median period of 72.5 months (interquartile range, 37.7–111.3 mo). Of them, 16 SELs (4.0%) showed substantial changes in size or morphology at a median follow-up of 35.1 months (interquartile range, 21.7–51.4 mo). Of these SELs with substantial changes, tissues of two SELs were acquired using endoscopic ultrasound-guided fine needle aspiration biopsy: one was a lipoma and the other was non-diagnostic. Three SELs were surgically or endoscopically removed; two were diagnosed as gastrointestinal stromal tumors, and one was a lipoma. An initial size of 20 mm or larger was associated with substantial changes during follow-up (p = 0.016). Conclusions: While the majority of duodenal SELs may not exhibit substantial interval changes, regular follow-up with endoscopy may be necessary for cases with an initial size of 20 mm or larger, considering a possibility of malignancy.
참고문헌 (30)
- Papanikolaou IS, "Endoscopic ultrasonography for gastric submucosal lesions", World J Gastrointest Endosc, 3, pp.86~94 (2011)
- Sharzehi K, "AGA clinical practice update on management of subepithelial lesions encountered during routine endoscopy : expert review", Clin Gastroenterol Hepatol, 20, pp.2435~2443 (2022)
- Faulx AL, "The role of endoscopy in subepithelial lesions of the GI tract", Gastrointest Endosc, 85, pp.1117~1132 (2017)
- Cho JW, "Current guidelines in the management of upper gastrointestinal subepithelial tumors", Clin Endosc, 49, pp.235~240 (2016)
- Deprez PH, "Endoscopic management of subepithelial lesions including neuroendocrine neoplasms : European Society of Gastrointestinal Endoscopy(ESGE)Guideline", Endoscopy, 54, pp.412~429 (2022)
- Ko WJ, "Evaluation and endoscopic management of esophageal submucosal tumor", Clin Endosc, 50, pp.250~253 (2017)
- Lim YJ, "Clinical course of subepithelial lesions detected on upper gastrointestinal endoscopy", World J Gastroenterol, 16, pp.439~444 (2010)
- Kim TW, "Endoscopic resection for duodenal subepithelial tumors : a single-center experience", Surg Endosc, 31, pp.1936~1946 (2017)
- Granata A, "Exposed endoscopic full-thickness resection for duodenal submucosal tumors : current status and future perspectives", World J Gastrointest Endosc, 14, pp.77~84 (2022)
- Li C, "Safety and efficacy of endoscopic resection for the treatment of duodenal subepithelial lesions", J Gastrointest Oncol, 12, pp.856~863 (2021)
- Gill KR, "The natural history of upper gastrointestinal subepithelial tumors : a multicenter endoscopic ultrasound survey", J Clin Gastroenterol, 43, pp.723~726 (2009)
- Bruno M, "The natural history of gastrointestinal subepithelial tumors arising from muscularis propria : an endoscopic ultrasound survey", J Clin Gastroenterol, 43, pp.821~825 (2009)
- Song JH, "Risk of progression for incidental small subepithelial tumors in the upper gastrointestinal tract", Endoscopy, 47, pp.675~679 (2015)
- Kim D, "Natural course of asymptomatic upper gastrointestinal subepithelial lesion of 2 cm or less in size", J Clin Med, 11, pp.7506~ (2022)
- Landi B, "The role of endosonography in submucosal tumours", Best Pract Res Clin Gastroenterol, 23, pp.679~701 (2009)
- Rösch T, "Accuracy of endoscopic ultrasonography in upper gastrointestinal submucosal lesions : a prospective multicenter study", Scand J Gastroenterol, 37, pp.856~862 (2002)
- Ji JS, "Diagnostic yield of tissue sampling using a bite-on-bite technique for incidental subepithelial lesions", Korean J Intern Med, 24, pp.101~105 (2009)
- Dumonceau JM, "Indications, results, and clinical impact of endoscopic ultrasound(EUS)-guided sampling in gastroenterology : European Society of Gastrointestinal Endoscopy(ESGE)Clinical Guideline-Updated January 2017", Endoscopy, 49, pp.695~714 (2017)
- Akahoshi K, "Current clinical management of gastrointestinal stromal tumor", World J Gastroenterol, 24, pp.2806~2817 (2018)
- Larghi A, "Fine-needle tissue acquisition from subepithelial lesions using a forward-viewing linear echoendoscope", Endoscopy, 46, pp.39~45 (2014)
- Cağlar E, "Concordance of endoscopic ultrasonography-guided fine needle aspiration diagnosis with the final diagnosis in subepithelial lesions", Clin Endosc, 46, pp.379~383 (2013)
- Jung YS, "Using forceps biopsy after small submucosal dissection in the diagnosis of gastric subepithelial tumors", J Korean Med Sci, 31, pp.1768~1774 (2016)
- Lee M, "Feasibility and diagnostic yield of endoscopic ultrasonography-guided fine needle biopsy with a new core biopsy needle device in patients with gastric subepithelial tumors", Medicine(Baltimore), 94, pp.e1622~ (2015)
- Han JP, "EUS-guided FNA and FNB after on-site cytological evaluation in gastric subepithelial tumors", J Dig Dis, 17, pp.582~587 (2016)
- Lee JH, "EUS-guided 22-gauge fine needle biopsy for the diagnosis of gastric subepithelial tumors larger than 2 cm", Scand J Gastroenterol, 51, pp.486~493 (2016)
- Sepe PS, "EUS-guided FNA for the diagnosis of GI stromal cell tumors : sensitivity and cytologic yield", Gastrointest Endosc, 70, pp.254~261 (2009)
- Pih GY, "Endoscopic ultrasound-guided fine needle aspiration and biopsy in gastrointestinal subepithelial tumors", Clin Endosc, 52, pp.314~320 (2019)
- Borbath I, "ENETS standardized(synoptic)reporting for endoscopy in neuroendocrine tumors", J Neuroendocrinol, 34, pp.e13105~ (2022)
- Exarchou K, "A"watch and wait"strategy involving regular endoscopic surveillance is safe for many patients with small, sporadic, grade 1, non-ampullary, non-functioning duodenal neuroendocrine tumours", Neuroendocrinology, 111, pp.764~774 (2021)
- Panzuto F, "European Neuroendocrine Tumor Society(ENETS)2023 guidance paper for gastroduodenal neuroendocrine tumours(NETs)G1-G3", J Neuroendocrinol, 35, pp.e13306~ (2023)